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Introduction
The anogenital distance (AGD) is identified as the length 
between labia posterior commissure and the centre of the 
anus measured in millimetres. Its size depends on hor-
monal changes, particularly in estrogen and androgen level 
modifications.1~3 The relationship between AGD and sex 
steroids is still well known, considering that AGD has been 
used as bioindicator of fetal androgen exposure in humans 
and specifically to estimate the consequences of adverse in 
utero hormonal exposure.3~7 Menopause hormonal varia-
tions are responsible of several anatomical and physiologi-
cal changes in internal and external genitalia. Decreasing 
estrogen levels, the production of collagen changes with an 
increase in collagen strength, skin elasticity reduces and 
genitalia water content declines severely. Generally, genita-
lia trophism is dramatically affected by menopause, having 
in women a negative effect on intimacy and even on quality 
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of life. Recent studies, confirm that one of the most severe 
menopause-related problem is vulvovaginal atrophy (VVA), 
involving more than 50% of women in Europe and reaching 
over 78% in Italian population.8,9
Nevertheless, there is a lack of studies on anatomi-
cal changes in adult females. This is a pilot study aimed to 
evaluate anatomical and morphological changes and com-
parison between pre-menopausal and post-menopausal 
women, focused on AGD and vaginal health index (VHI) 
modifications.
Materials and Methods
A total of 109 patients have been identified, recruited and 
enrolled in the outpatient clinic at the Department of Ob-
stetrics and Gynecology, “Sapienza” University of Rome be-
tween April 2016 and December 2016.
Inclusion criteria for premenopausal group were: age be-
tween 20 and 45 years, regular periods in the past 1-year 
(intervals of 20-45 days). Inclusion criteria for premeno-
pausal group were: age between 45 to 80 years, physiologic 
menopause since at least 1 year.
Exclusion criteria in both groups were: gynecological sur-
geries in the past affecting fertility and hormone production 
(e.g., oophorectomy), chemotherapy or irradiation of the 
pelvis, hormonal treatment in the previous year (combined 
oral contraceptives or hormone replacement therapy), con-
genital anatomical abnormalities, pregnancy, breastfeeding, 
severe comorbidities (e.g., autoimmune diseases, diabetes, 
etc.), infections, bleeding, and tumors.
All patients were extensively informed of study design and 
hypothesis. Written informed consent was obtained by all 
patients enrolled. Institutional Review Board (IRB) provided 
exempt to ethical approval. The present study was conducted 
following the principles of the Declaration of Helsinki. Can-
didates were consecutively randomized in the 2 groups.
Patients’ data (height, weight, body mass index [BMI], 
AGD) were collected in the same day during outpatient ex-
amination. AGD measurement was conducted using a paper 
ruler in the lithotomy position to define the distance be-
tween posterior commissure of labia and anus centre (Fig. 1). 
Anogenital index (AGI) was used to control 2 variables of 
height and weight,10 by dividing AGD by BMI (kg/m2).
VHI11 was used to evaluate vaginal wellness by analysing 
5 parameters by clinical inspection: elasticity, fluid volume, 
pH, epithelial integrity and moisture (Table 1). Each param-
eter is graded from 1 (worst condition) to 5 (best condition). 
Scores ≤15 are considered to denote vaginal atrophy.
Female sexual function index (FSFI) questionnaire was 
administered to all women to evaluate the impact of geni-
talia changes on sexual life. FSFI is a validated, multidi-
mensional, self-reported questionnaire to assess female 
sexual function.12 It consists of 19 items evaluating the FSFI 
lubrication, sexual arousal, orgasm, sexual satisfaction, and 
pain. The total score (range, 2-36; severe sexual dysfunc-
tion to full sexual function respectively) is calculated by 
summing the 5-domain score and interpreted by compari-
son with age- and population-dependent reference values 
for normal and impaired sexual function. A FSFI score ≤
26.55 is considered to indicate sexual dysfunction.13
Interval data were analysed using the Mann-Whitney U 
test. Nominal data were evaluated using χ2 test or Fisher’s ex-
act test when appropriate. Parameters are expressed as as 
mean ± standard deviation (SD) and 95% confidence inter-
val (CI). All statistical tests were performed using SPSS sta-
tistical software program (SPSS 20.0; SPSS Inc., Chicago, 
IL, USA). All P values of less than 0.05 were considered to 
indicate statistical significance.
AGDPosterior commissure of labia
Center of the anus
Fig. 1. Anogenital distance (AGD).
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Results
To compare AGD in relation with VHI and FSFI of pre-
menopausal and postmenopausal women, a total of 109 
subjects were examined, being 48 in premenopause and 61 
in menopause.
Patients’ characteristics are shown in Table 2. BMI signif-
icantly varied between 2 groups (22.34 ± 2.84 vs. 25.36 ± 
3.59; P = 0.0001), probably in relation to metabolic changes 
happening during menopause. AGD (30.87 ± 2.98 vs. 17.57 ± 
2.18; P = 0.0001) and AGI (1.40 ± 0.21 vs. 0.70 ± 0.15; P = 
0.0001) were both significantly lower in the postmenopausal 
group. Comparison between AGD in the 2 groups is evalu-
able in Figure 2 as well.
As highlighted in Table 2, postmenopausal women were 
affected by VVA significantly and negatively compared with 
premenopausal patients. Thus, VHI scores were dramatically 
worse in postmenopausal group (23.95 ± 1.28 vs. 10.75 ± 
3.41; P = 0.0001) as well as FSFI results (32.68 ± 2.25 vs. 
19.78 ± 5.46; P = 0.0001). Specific data on VHI and FSFI 
are shown in Figure 3 and 4 respectively.
 
Table 1. Vaginal health index
Score 1 2 3 4 5
Elasticity None Poor Fair Good Excellent
Fluid volume None Scar amount, vault not 
entirely covered
Superficial amount, 
vault entirely covered
Moderate amount Normal amount
pH ≥6.1 5.6-6.0 5.1-5.5 4.7-5.0 ≤4.6
Epithelial integrity Petechiae noted before 
contact
Bleeds with light contact Bleeds with scraping Not friable, thin 
epithelium
Normal
Moisture None, surface inflamed None, surface not in-
flamed
Minimal Moderate Normal
Table 2. Characteristics of patients
Variables Premenopausal women (n = 48) Postmenopausal women (n = 61) P value
Age (years) 28.48 ± 6.54 (25.6-30.4) 62.39 ± 7.14 (60.5-64.2) 0.0001
BMI (kg/m2) 22.34 ± 2.84 (21.5-23.2) 25.36 ± 3.59 (24.4-26.3) 0.0001
AGD (mm) 30.87 ± 2.98 (30.0-31.7) 17.57 ± 2.18 (17.0-18.1) 0.0001
AGI 1.40 ± 0.21 (1.3-1.5) 0.70 ± 0.15 (0.6-0.7) 0.0001
VHI score 23.95 ± 1.28 (23.6-24.3) 10.75 ± 3.41 (9.9-11.6) 0.0001
FSFI score 32.68 ± 2.25 (32.0-33.3) 19.78 ± 5.46 (18.4-21.2) 0.0001
The data is presented as mean ± standard deviation (95% confidence interval)
BMI: body mass index, AGD: anogenital distance, AGI: anogenital index, VHI: vaginal health index, FSFI: female sexual function index
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Fig. 2. Comparison between premenopause and postmenopause 
values of anogenital distance (AGD) (P < 0.0001).
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Discussion
AGD has been frequently investigated in newborn in-
fants and adult males but lacking evidences are present in 
women.14 Moreover, in animal tests, AGD was usually used 
to evaluate drug toxicity. For instance, phthalates are syn-
thetic chemical compound used in cosmetics and it have 
been demonstrated as responsible of a shortening of AGD in 
rodents.5,15,16
On the other hand, AGD length is positively influenced by 
male sex hormones, becoming longer.17~19
In fact, AGD may be considered as an alternative bio-
marker of foetal testicular function, reflecting androgen 
action during the masculinisation process in animal models. 
This developmental androgen exposure allows normal dif-
ferentiation and subsequent growth of male reproductive 
organs.3,20,21
To our knowledge there is just another study investigating 
on AGD modifications before and after menopause.11 Lee and 
colleagues11 analysed 50 women (25 premenopause and 25 
postmenopause) suggesting AGD and AGI as possible physi-
cal marker of menopausal aging of female genitalia.
As in our study, AGD was significantly longer in pre-
menopausal women compared to postmenopausal women 
(34.8 ± 6.4 vs. 30.3 ± 6.6, P = 0.019). AGI was signifi-
cantly higher in premenopausal women than postmeno-
pausal women (1.7 ± 0.4 vs. 1.3 ± 0.3, P < 0.0001).
Menopause is responsible of several female physical 
changes having an important influence on the whole body. 
Skin elasticity, bone production/resorption, female genitalia 
trophism or function and cardiovascular system are entirely 
influenced by hormonal changes occurring in postmeno-
pause.
This study confirms that AGD in postmenopausal women 
was significantly shorter than AGD in premenopausal wom-
en, correlating with an increase of VVA and sexual impair-
ment.
Probably, AGD length modification can be the result of a 
decrease in collagen production, atrophoderma, a drop-in 
water content and epidermal thickness reduction caused by 
the decreased production of sex hormones after menopause. 
Conclusion
According to the results, AGD can be used as a metric to 
predict the changes related to menopause. Certainly, further 
studies are needed to confirm and standardize its use in 
clinical practice.
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Fig. 3. Distribution of vaginal health index (VHI) scores in the 
premenopausal and postmenopausal group.
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